A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

INTRODUCTION: Patients with primary operable oestrogen receptor (ER) negative (-) breast cancer account for about 30% of all cases and generally have a worse prognosis than ER-positive (+) patients. Nevertheless, a significant proportion of ER- cases have favourable outcomes and could potentially be...

Descripción completa

Detalles Bibliográficos
Autores principales: Teschendorff, Andrew E, Caldas, Carlos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575547/
https://www.ncbi.nlm.nih.gov/pubmed/18755024
http://dx.doi.org/10.1186/bcr2138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575547/
https://www.ncbi.nlm.nih.gov/pubmed/18755024
http://dx.doi.org/10.1186/bcr2138

Ejemplares similares